| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Alamar Biosciences, Inc.
13D
ALMR · 010911105
|
9.6% |
4/23/2026
Event 4/20/2026
|
||||
| Illumina Innovation Fund II GP, L.L.C. | 8.8% | |||||
| Illumina Innovation Fund II, L.P. | 8.8% | |||||
| Illumina Innovation Fund III GP, L.L.C. | 0.8% | |||||
| Illumina Innovation Fund III, L.P. | 0.8% | |||||
| Nicholas Naclerio | 9.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.